Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S3W-04180 · Session 3

Further to the answer to question S2W-31920 by Mr Andy Kerr on 27 February 2007, whether, following the approval of Lucentis® (ranibizumab)…

Answered Asked by Des McNulty Lab Lodged 10 Sep 2007

The question

To ask the Scottish Executive, further to the answer to question S2W-31920 by Mr Andy Kerr on 27 February 2007, whether, following the approval of Lucentis® (ranibizumab) on 22 January 2007 by the European Medicines Evaluation Agency, the Scottish Medicines Consortium has made a recommendation regarding the use of this therapy.

The answer

Answered by Shona Robison on 18 Sep 2007 · 8 days after it was lodged, on time

The ScottishMedicines Consortium recommended Lucentis for use in NHS Scotland on 11 June 2007. Further information is available at: www.scottishmedicines.org.

In the Official Report

No contribution in the Official Report cites S3W-04180 by reference.